Mis-Dis Information in COVID-19 Health Crisis: A Narrative Review.

Vicente Javier Clemente-Suárez, Eduardo Navarro-Jiménez, Juan Antonio Simón-Sanjurjo, Ana Isabel Beltran-Velasco, Carmen Cecilia Laborde-Cárdenas, Juan Camilo Benitez-Agudelo, Álvaro Bustamante-Sánchez, José Francisco Tornero-Aguilera
Author Information
  1. Vicente Javier Clemente-Suárez: Faculty of Sports Sciences, Universidad Europea de Madrid, Tajo Street, s/n, 28670 Madrid, Spain. ORCID
  2. Eduardo Navarro-Jiménez: Grupo de Investigacion en Microbiologia y Biotecnologia (IMB), Universidad Libre, Barranquilla 080002, Colombia.
  3. Juan Antonio Simón-Sanjurjo: Faculty of Sports Sciences, Universidad Europea de Madrid, Tajo Street, s/n, 28670 Madrid, Spain. ORCID
  4. Ana Isabel Beltran-Velasco: Psychology Department, Universidad Antonio de Nebrija, 28240 Madrid, Spain. ORCID
  5. Carmen Cecilia Laborde-Cárdenas: Vicerrectoría de Investigación e Innovación, Universidad Simón Bolívar, Barranquilla 080005, Colombia. ORCID
  6. Juan Camilo Benitez-Agudelo: Facultad de Ciencias Sociales y Humanas, Universidad de la Costa, Barranquilla 080002, Colombia. ORCID
  7. Álvaro Bustamante-Sánchez: Faculty of Sports Sciences, Universidad Europea de Madrid, Tajo Street, s/n, 28670 Madrid, Spain. ORCID
  8. José Francisco Tornero-Aguilera: Faculty of Sports Sciences, Universidad Europea de Madrid, Tajo Street, s/n, 28670 Madrid, Spain. ORCID

Abstract

BACKGROUND: In this narrative review, we address the COVID-19 pandemic mis-dis information crisis in which healthcare systems have been pushed to their limits, with collapses occurring worldwide. The context of uncertainty has resulted in skepticism, confusion, and general malaise among the population. Informing the public has been one of the major challenges during this pandemic. Misinformation is defined as false information shared by people who have no intention of misleading others. Disinformation is defined as false information deliberately created and disseminated with malicious intentions.
OBJECTIVE: To reach a consensus and critical review about mis-dis information in COVID-19 crisis.
METHODS: A database search was conducted in PsychINFO, MedLine (Pubmed), Cochrane (Wiley), Embase and CinAhl. Databases used the MeSH-compliant keywords of COVID-19, 2019-nCoV, Coronavirus 2019, SARS-CoV-2, misinformation, disinformation, information, vaccines, vaccination, origin, target, spread, communication.
RESULTS: Both misinformation and disinformation can affect the population's confidence in vaccines (development, safety, and efficacy of vaccines, as well as denial of the severity of SARS-CoV infection). Institutions should take into account that a great part of the success of the intervention to combat a pandemic has a relationship with the power to stop the misinformation and disinformation processes. The response should be well-structured and addressed from different key points: central level and community level, with official and centralized communication channels. The approach should be multifactorial and enhanced by the collaboration of social media companies to stop misleading information, and trustworthy people both working or not working in the health care systems to boost the power of the message.
CONCLUSIONS: The response should be well-structured and addressed from different key points: central level and community level, with official and clearly centralized communication channels. The approach should be multifactorial and enhanced from the collaboration of social media companies to stop misleading information, and trustworthy people both working and not working in the health care systems to boost the power of a message based on scientific evidence.

Keywords

References

  1. Lancet. 2020 Apr 11;395(10231):1194 [PMID: 32246915]
  2. Perm J. 2018 Jun 11;22:17-138 [PMID: 29911966]
  3. Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593 [PMID: 32693678]
  4. Sci Total Environ. 2020 Aug 1;728:138813 [PMID: 32334159]
  5. Lancet Public Health. 2020 May;5(5):e253 [PMID: 32220653]
  6. JMIR Public Health Surveill. 2020 May 22;6(2):e19447 [PMID: 32412418]
  7. PLoS One. 2021 May 12;16(5):e0251605 [PMID: 33979412]
  8. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  9. Environ Dev Sustain. 2021;23(4):5005-5015 [PMID: 32837273]
  10. Int J Environ Res Public Health. 2021 Aug 12;18(16): [PMID: 34444255]
  11. Health Expect. 2021 Aug;24(4):1158-1167 [PMID: 33942948]
  12. J Health Commun. 2020 Mar 3;25(3):232-242 [PMID: 32154770]
  13. Arch Acad Emerg Med. 2020 Mar 12;8(1):e19 [PMID: 32185370]
  14. J Public Health Manag Pract. 2020 May/Jun;26(3):294-296 [PMID: 32235211]
  15. Cyberpsychol Behav Soc Netw. 2021 Aug;24(8):573-577 [PMID: 33395548]
  16. Nat Hum Behav. 2021 Mar;5(3):337-348 [PMID: 33547453]
  17. Health Commun. 2020 Dec;35(14):1718-1722 [PMID: 33124475]
  18. Langenbecks Arch Surg. 2021 Mar;406(2):385-391 [PMID: 33277682]
  19. Lancet. 1998 Feb 28;351(9103):637-41 [PMID: 9500320]
  20. Indian J Psychiatry. 2011 Apr;53(2):95-6 [PMID: 21772639]
  21. Sci Commun. 2020 Oct;42(5):586-615 [PMID: 38603002]
  22. Hum Vaccin Immunother. 2021 Aug 3;17(8):2373-2377 [PMID: 33764283]
  23. Transl Behav Med. 2020 Oct 8;10(4):850-856 [PMID: 32910819]
  24. Environ Dev Sustain. 2020;22(5):3861-3865 [PMID: 34172977]
  25. Can Pharm J (Ott). 2021 Feb 17;154(2):68-69 [PMID: 33868512]
  26. J Public Health (Oxf). 2021 Dec 10;43(4):695-702 [PMID: 33693905]
  27. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15): [PMID: 33837156]
  28. Inf Process Manag. 2021 Mar;58(2):102440 [PMID: 33281273]
  29. JMIR Public Health Surveill. 2020 Apr 9;6(2):e18444 [PMID: 32250960]
  30. Rev Salud Publica (Bogota). 2023 Feb 3;22(4):447-452 [PMID: 36753245]
  31. Online Soc Netw Media. 2021 Mar;22:100104 [PMID: 33623836]
  32. Prog Disaster Sci. 2020 Dec;8:100119 [PMID: 34173443]
  33. Lancet. 2020 Feb 29;395(10225):685-686 [PMID: 32059801]
  34. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3 [PMID: 33625960]
  35. AIDS Behav. 2020 Oct;24(10):2776-2780 [PMID: 32440972]
  36. Physiol Behav. 2022 Feb 1;244:113667 [PMID: 34861297]
  37. EClinicalMedicine. 2020 Sep;26:100495 [PMID: 32838242]
  38. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  39. PLoS One. 2020 Oct 14;15(10):e0240005 [PMID: 33052967]
  40. JMIR Public Health Surveill. 2020 Oct 8;6(4):e21071 [PMID: 32936775]
  41. Arthritis Rheumatol. 2020 Nov;72(11):1806-1808 [PMID: 32741134]
  42. R Soc Open Sci. 2020 Oct 14;7(10):201199 [PMID: 33204475]
  43. Eur J Emerg Med. 2020 Oct;27(5):327-328 [PMID: 32332201]
  44. PLoS One. 2021 May 12;16(5):e0251095 [PMID: 33979370]
  45. Int J Environ Res Public Health. 2021 Sep 24;18(19): [PMID: 34639341]
  46. Vaccines (Basel). 2021 Jul 21;9(8): [PMID: 34451934]
  47. Epidemiol Health. 2016 Nov 5;38:e2016048 [PMID: 28196409]
  48. Clin Exp Pediatr. 2020 Dec;63(12):477-482 [PMID: 33152743]
  49. J Korean Med Sci. 2020 Jul 13;35(27):e256 [PMID: 32657090]
  50. J Med Internet Res. 2020 Nov 12;22(11):e23922 [PMID: 33151897]
  51. Int J Environ Res Public Health. 2021 Apr 28;18(9): [PMID: 33924796]
  52. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):705-709 [PMID: 32525852]
  53. SN Compr Clin Med. 2020;2(9):1287-1289 [PMID: 32838179]
  54. Sci Rep. 2021 Mar 23;11(1):6626 [PMID: 33758218]
  55. Sci Transl Med. 2012 Jun 13;4(138):138ed6 [PMID: 22648982]
  56. Int J Environ Res Public Health. 2021 May 14;18(10): [PMID: 34068866]
  57. J Med Internet Res. 2020 May 6;22(5):e19458 [PMID: 32352383]
  58. Compr Psychiatry. 2012 Jan;53(1):15-23 [PMID: 21489421]
  59. Am J Public Health. 2018 Oct;108(10):1378-1384 [PMID: 30138075]
  60. Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7662-7669 [PMID: 30642953]
  61. Policy Sci. 2020;53(4):735-758 [PMID: 32921821]
  62. Lancet. 2020 Feb 29;395(10225):676 [PMID: 32113495]
  63. JMIR Ment Health. 2020 Jul 6;7(7):e19246 [PMID: 32484783]
  64. Lancet Public Health. 2020 May;5(5):e251-e252 [PMID: 32199083]
  65. NPJ Vaccines. 2021 May 14;6(1):73 [PMID: 33990614]
  66. BMC Public Health. 2021 Jan 7;21(1):89 [PMID: 33413219]
  67. EClinicalMedicine. 2021 Mar;33:100780 [PMID: 33718854]
  68. Vaccines (Basel). 2021 Feb 01;9(2): [PMID: 33535716]
  69. Nat Rev Endocrinol. 2019 May;15(5):288-298 [PMID: 30814686]
  70. J Health Commun. 2021 Jul 3;26(7):443-459 [PMID: 34346288]
  71. Hum Vaccin Immunother. 2017 Aug 3;13(8):1895-1901 [PMID: 28481675]
  72. Early Hum Dev. 2020 Nov 12;:105256 [PMID: 33221032]
  73. J Med Internet Res. 2021 Jun 2;23(6):e28253 [PMID: 33900934]
  74. Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504 [PMID: 34325612]
  75. EClinicalMedicine. 2021 Mar;33:100772 [PMID: 33655205]
  76. J Inf Sci. 2023 Aug;49(4):1096-1110 [PMID: 37461399]
  77. Lancet. 2020 Mar 21;395(10228):945-947 [PMID: 32145186]
  78. BMJ. 2011 Jan 05;342:c7452 [PMID: 21209060]
  79. Med Hypotheses. 2011 Jul;77(1):7-10 [PMID: 21444159]
  80. Wellcome Open Res. 2021 Aug 16;6:23 [PMID: 38872924]
  81. Health Info Libr J. 2021 Jun;38(2):143-149 [PMID: 32657000]
  82. Nutrients. 2021 Jun 03;13(6): [PMID: 34205138]
  83. J Prev Med Public Health. 2020 May;53(3):171-174 [PMID: 32498140]
  84. Int J Public Health. 2020 Jul;65(6):713-714 [PMID: 32601723]
  85. Vaccines (Basel). 2020 May 19;8(2): [PMID: 32438622]

MeSH Term

COVID-19
Communication
Humans
Pandemics
SARS-CoV-2
Social Media

Word Cloud

Created with Highcharts 10.0.0informationCOVID-19pandemicmisinformationdisinformationlevelworkingcrisissystemspeoplemisleadingvaccinescommunicationpowerstopsocialmediahealthreviewmis-disdefinedfalseresponsewell-structuredaddresseddifferentkeypoints:centralcommunityofficialcentralizedchannelsapproachmultifactorialenhancedcollaborationcompaniestrustworthycareboostmessageBACKGROUND:narrativeaddresshealthcarepushedlimitscollapsesoccurringworldwidecontextuncertaintyresultedskepticismconfusiongeneralmalaiseamongpopulationInformingpubliconemajorchallengesMisinformationsharedintentionothersDisinformationdeliberatelycreateddisseminatedmaliciousintentionsOBJECTIVE:reachconsensuscriticalMETHODS:databasesearchconductedPsychINFOMedLinePubmedCochraneWileyEmbaseCinAhlDatabasesusedMeSH-compliantkeywords2019-nCoVCoronavirus2019SARS-CoV-2vaccinationorigintargetspreadRESULTS:canaffectpopulation'sconfidencedevelopmentsafetyefficacywelldenialseveritySARS-CoVinfectionInstitutionstakeaccountgreatpartsuccessinterventioncombatrelationshipprocessesCONCLUSIONS:clearlybasedscientificevidenceMis-DisInformationHealthCrisis:NarrativeReview

Similar Articles

Cited By